Christopher W Vaughan - Publications

Affiliations: 
2000- Kolling Institute University of Sydney, Australia 
Area:
Pain, cannabinoids, synaptic transmission

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Winters BL, Lau BK, Vaughan CW. Cannabinoids and Opioids Differentially Target Extrinsic and Intrinsic GABAergic Inputs onto the Periaqueductal Grey Descending Pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 42: 7744-7756. PMID 36414010 DOI: 10.1523/JNEUROSCI.0997-22.2022  0.718
2020 Devenish SO, Winters BL, Anderson LL, Arnold JC, McGregor IS, Vaughan CW, Chebib M, Absalom NL. The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrations. Neuropharmacology. 108371. PMID 33122032 DOI: 10.1016/j.neuropharm.2020.108371  0.302
2020 Konen LM, Wright AL, Royle GA, Morris GP, Lau BK, Seow PW, Zinn R, Milham LT, Vaughan CW, Vissel B. A new mouse line with reduced GluA2 Q/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independent seizure vulnerability. Molecular Brain. 13: 27. PMID 32102661 DOI: 10.1186/S13041-020-0545-1  0.618
2020 Lau BK, Winters BL, Vaughan CW. Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway. British Journal of Pharmacology. PMID 31971607 DOI: 10.1111/bph.14982  0.682
2019 Atwal N, Winters BL, Vaughan CW. Endogenous cannabinoid modulation of restraint stress-induced analgesia in thermal nociception. Journal of Neurochemistry. PMID 31571215 DOI: 10.1111/jnc.14884  0.342
2019 Winters BL, Christie MJ, Vaughan CW. Correction to: Electrophysiological Actions of N/OFQ. Handbook of Experimental Pharmacology. PMID 31152275 DOI: 10.1007/164_2019_240  0.403
2019 Winters BL, Christie MJ, Vaughan CW. Electrophysiological Actions of N/OFQ. Handbook of Experimental Pharmacology. PMID 30838458 DOI: 10.1007/164_2019_205  0.622
2017 Wilson-Poe AR, Jeong HJ, Vaughan CW. Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance. The Journal of Physiology. PMID 28815604 DOI: 10.1113/JP274157  0.368
2017 Wingerd JS, Mozar CA, Ussing CA, Murali SS, Chin YK, Cristofori-Armstrong B, Durek T, Gilchrist J, Vaughan CW, Bosmans F, Adams DJ, Lewis RJ, Alewood PF, Mobli M, Christie MJ, et al. The tarantula toxin β/δ-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity. Scientific Reports. 7: 974. PMID 28428547 DOI: 10.1038/S41598-017-01129-0  0.443
2016 Aubrey KR, Drew GM, Jeong HJ, Lau BK, Vaughan CW. Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses. The Journal of Physiology. PMID 27461371 DOI: 10.1113/Jp272292  0.643
2016 Kazantzis NP, Casey SL, Seow PW, Mitchell VA, Vaughan CW. Opioid and cannabinoid synergy in a mouse neuropathic pain model. British Journal of Pharmacology. PMID 27278681 DOI: 10.1111/bph.13534  0.325
2014 Redmond WJ, Camo M, Mitchell V, Vaughan CW, Connor M. Nordihydroguaiaretic acid activates hTRPA1 and modulates behavioral responses to noxious cold in mice. Pharmacology Research & Perspectives. 2: e00079. PMID 25505619 DOI: 10.1002/prp2.79  0.47
2014 Lau BK, Vaughan CW. Descending modulation of pain: the GABA disinhibition hypothesis of analgesia. Current Opinion in Neurobiology. 29: 159-64. PMID 25064178 DOI: 10.1016/j.conb.2014.07.010  0.695
2014 Lau BK, Drew GM, Mitchell VA, Vaughan CW. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. British Journal of Pharmacology. 171: 5225-36. PMID 25041240 DOI: 10.1111/bph.12839  0.633
2014 Lau BK, Vaughan CW. Targeting the endogenous cannabinoid system to treat neuropathic pain. Frontiers in Pharmacology. 5: 28. PMID 24624084 DOI: 10.3389/fphar.2014.00028  0.576
2014 Lau BK, Karim S, Goodchild AK, Vaughan CW, Drew GM. Menthol enhances phasic and tonic GABAA receptor-mediated currents in midbrain periaqueductal grey neurons. British Journal of Pharmacology. 171: 2803-13. PMID 24460753 DOI: 10.1111/Bph.12602  0.694
2013 Wilson-Poe AR, Mitchell VA, Vaughan CW. Postsynaptic mGluR mediated excitation of neurons in midbrain periaqueductal grey. Neuropharmacology. 66: 348-54. PMID 22771462 DOI: 10.1016/j.neuropharm.2012.06.057  0.433
2011 Pedersen NP, Vaughan CW, Christie MJ. Opioid receptor modulation of GABAergic and serotonergic spinally projecting neurons of the rostral ventromedial medulla in mice. Journal of Neurophysiology. 106: 731-40. PMID 21593395 DOI: 10.1152/jn.01062.2010  0.75
2011 Mitchell VA, Jeong HJ, Drew GM, Vaughan CW. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1801-10. PMID 21525858 DOI: 10.1038/npp.2011.59  0.475
2011 Christie MJ, Vaughan CW. Receptors: cannabis medicine without a high. Nature Chemical Biology. 7: 249-50. PMID 21502945 DOI: 10.1038/nchembio.567  0.532
2010 Wrigley PJ, Jeong HJ, Vaughan CW. Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn. Molecular Pain. 6: 71. PMID 20977770 DOI: 10.1186/1744-8069-6-71  0.496
2010 Jeong HJ, Vandenberg RJ, Vaughan CW. N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn. British Journal of Pharmacology. 161: 925-35. PMID 20860669 DOI: 10.1111/J.1476-5381.2010.00935.X  0.367
2009 Drew GM, Lau BK, Vaughan CW. Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 7220-9. PMID 19494144 DOI: 10.1523/JNEUROSCI.4362-08.2009  0.693
2009 Wrigley PJ, Jeong HJ, Vaughan CW. Primary afferents with TRPM8 and TRPA1 profiles target distinct subpopulations of rat superficial dorsal horn neurones. British Journal of Pharmacology. 157: 371-80. PMID 19371346 DOI: 10.1111/j.1476-5381.2009.00167.x  0.42
2008 Jeong HJ, Chenu D, Johnson EE, Connor M, Vaughan CW. Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Molecular Pain. 4: 54. PMID 19014464 DOI: 10.1186/1744-8069-4-54  0.576
2008 Lau BK, Vaughan CW. Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray. Molecular Pharmacology. 74: 1392-8. PMID 18678620 DOI: 10.1124/mol.108.045872  0.668
2008 Drew GM, Mitchell VA, Vaughan CW. Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 808-15. PMID 18216189 DOI: 10.1523/JNEUROSCI.4876-07.2008  0.351
2008 Vuong LA, Mitchell VA, Vaughan CW. Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology. 54: 189-93. PMID 17588618 DOI: 10.1016/j.neuropharm.2007.05.004  0.313
2005 Drew GM, Mitchell VA, Vaughan CW. Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro. Neuropharmacology. 49: 587-95. PMID 15921708 DOI: 10.1016/j.neuropharm.2005.04.011  0.392
2005 Bagley EE, Gerke MB, Vaughan CW, Hack SP, Christie MJ. GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron. 45: 433-45. PMID 15694329 DOI: 10.1016/j.neuron.2004.12.049  0.614
2005 Connor M, Vaughan CW. Humanizing mice: catching up with elusive B1 receptors. British Journal of Pharmacology. 144: 885-6. PMID 15685198 DOI: 10.1038/sj.bjp.0706141  0.486
2004 Connor M, Bagley EE, Mitchell VA, Ingram SL, Christie MJ, Humphrey PP, Vaughan CW. Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro. British Journal of Pharmacology. 142: 1273-80. PMID 15265812 DOI: 10.1038/Sj.Bjp.0705894  0.749
2004 Marinelli S, Schnell SA, Hack SP, Christie MJ, Wessendorf MW, Vaughan CW. Serotonergic and nonserotonergic dorsal raphe neurons are pharmacologically and electrophysiologically heterogeneous. Journal of Neurophysiology. 92: 3532-7. PMID 15254076 DOI: 10.1152/jn.00437.2004  0.572
2004 Drew GM, Vaughan CW. Multiple metabotropic glutamate receptor subtypes modulate GABAergic neurotransmission in rat periaqueductal grey neurons in vitro. Neuropharmacology. 46: 927-34. PMID 15081789 DOI: 10.1016/j.neuropharm.2004.01.015  0.363
2003 Mitchell VA, Christie MJ, Vaughan CW. Developmental changes in the alpha-adrenergic responses of rat periaqueductal grey neurons. Neuroreport. 14: 1637-9. PMID 14502091 DOI: 10.1097/00001756-200308260-00019  0.504
2003 Hack SP, Vaughan CW, Christie MJ. Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology. 45: 575-84. PMID 12941371 DOI: 10.1016/S0028-3908(03)00205-3  0.621
2003 Vaughan CW, Bagley EE, Drew GM, Schuller A, Pintar JE, Hack SP, Christie MJ. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. British Journal of Pharmacology. 139: 362-7. PMID 12770941 DOI: 10.1038/sj.bjp.0705261  0.624
2002 Marinelli S, Vaughan CW, Schnell SA, Wessendorf MW, Christie MJ. Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 10847-55. PMID 12486178 DOI: 10.1523/Jneurosci.22-24-10847.2002  0.62
2002 Marinelli S, Vaughan CW, Christie MJ, Connor M. Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. The Journal of Physiology. 543: 531-40. PMID 12205187 DOI: 10.1113/jphysiol.2002.022863  0.7
Show low-probability matches.